Stefan Glombitza
Vorstandsvorsitzender bei FORMYCON AG
Aktive Positionen von Stefan Glombitza
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FORMYCON AG | Vorstandsvorsitzender | 01.07.2022 | - |
| Geschäftsführer | 01.10.2016 | 01.07.2022 |
Karriereverlauf von Stefan Glombitza
Ehemalige bekannte Positionen von Stefan Glombitza
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Hexal Pharmaforschung GmbH | Corporate Officer/Principal | - | - |
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Corporate Officer/Principal | 01.01.1995 | - |
Ausbildung von Stefan Glombitza
| University of Regensburg | Doctorate Degree |
Statistik
International
| Deutschland | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
| Hexal Pharmaforschung GmbH |
- Börse
- Insiders
- Stefan Glombitza
- Erfahrung
